Ledger.Open graph →
SEC Form D · filed October 3, 2022

Atelerix Life Sciences Inc

Offering
$3.5M
Sold
$650K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

David Kalergis · Charlottesville, VAExec · Director · PromoterPeter B. Hutt · Watertown, MADirectorWilliam Akridge · Charlottesville, VADirectorDavid Kalergis · Charlottesville, VAExec · Director · PromoterWilliam Akridge · Charlottesville, VADirectorPeter B. Hutt · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗